Factor VIII and platelets synergistically accelerate cleavage of von Willebrand factor by ADAMTS13 under fluid shear stress.
Previous studies have demonstrated that factor VIII (FVIII) or platelets alone increase cleavage of von Willebrand factor (VWF) by ADAMTS13 under mechanically induced shear stresses. We show in this study that the combination of FVIII and platelets at the physiological concentrations is more effective than either one alone. In the absence of FVIII, lyophilized platelets increase the formation of cleavage product by 2-3-fold. However, in the presence of physiological concentration of FVIII (1 nm), the formation of VWF cleavage product increases dramatically as a function of increasing platelets with the maximal rate enhancement of approximately 8-fold. Conversely, in the presence of a physiological concentration of lyophilized platelets (150 x 10(3)/microl), the half-maximal concentration of FVIII required to accelerate VWF proteolysis by ADAMTS13 reduces by approximately 10-fold (to approximately 0.3 nm) compared with that in the absence of platelets ( approximately 3.0 nm). Further studies using the FVIII derivative that lacks an acidic region (a3), an antiplatelet glycoprotein 1balpha IgG, and a purified recombinant VWF-A1 domain or glycoprotein 1balpha-stripped platelets demonstrate that the synergistic rate-enhancing effect of FVIII and platelets depends on their specific binding interactions with VWF. Our findings suggest that FVIII and platelets are cofactors that regulate proteolysis of multimeric VWF by ADAMTS13 under physiological conditions.
Skipwith
Christopher G
CG
Biochemistry and Molecular Biophysics Graduate Program, Children's Hospital of Philadelphia and the University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104, USA.
Cao
Wenjing
W
Zheng
X Long
XL
D051722:ADAM Proteins / Q000378:metabolism*; D000071120:ADAMTS13 Protein; D001792:Blood Platelets / Q000378:metabolism*; D002460:Cell Line; D005169:Factor VIII / Q000819:agonists* / Q000378:metabolism*; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology / Q000494:pharmacology; D039421:Integrin alpha2 / Q000276:immunology / Q000378:metabolism; D013312:Stress, Physiological; D014841:von Willebrand Factor / Q000378:metabolism*
D007074:Immunoglobulin G; D039421:Integrin alpha2; D014841:von Willebrand Factor; D005169:Factor VIII; D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human